Cargando…
Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases
SIMPLE SUMMARY: Based on Radiation Therapy Oncology Group (RTOG) 90-05, a maximum biologically effective dose (BED) of 45 Gy(12) is recommended for the stereotactic radiosurgery (SRS) of brain metastases measuring 21–30 mm. Given that patients on RTOG 90-05 received prior brain irradiation, the tole...
Autores principales: | Johannwerner, Leonie, Werner, Elisa M., Blanck, Oliver, Janssen, Stefan, Cremers, Florian, Yu, Nathan Y., Rades, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215316/ https://www.ncbi.nlm.nih.gov/pubmed/37237469 http://dx.doi.org/10.3390/biology12050655 |
Ejemplares similares
-
The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2023) -
Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013) -
A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases
por: Rades, Dirk, et al.
Publicado: (2017) -
The prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases
por: Martens, Kristina, et al.
Publicado: (2013) -
Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)